Alaunos Therapeutics, Inc.
TCRT
$2.19
$0.3015.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.99M | -4.07M | -4.68M | -11.78M | -19.13M |
| Total Depreciation and Amortization | -1.00K | 0.00 | 2.00K | 244.00K | 923.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 444.00K | 331.00K | 435.00K | 3.29M | 5.34M |
| Change in Net Operating Assets | 704.00K | -87.00K | -729.00K | -3.52M | -4.49M |
| Cash from Operations | -2.85M | -3.83M | -4.97M | -11.76M | -17.36M |
| Capital Expenditure | -- | -- | -- | 0.00 | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 1.50M | 1.51M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 1.50M | 1.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -125.00K | -125.00K |
| Issuance of Common Stock | 1.91M | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.35M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 125.00K | 125.00K |
| Cash from Financing | 3.26M | -- | -- | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 415.00K | -3.83M | -4.97M | -10.26M | -15.85M |